UK markets close in 1 hour 46 minutes

Sumitomo Pharma Co., Ltd. (DNPUF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.70000.0000 (0.00%)
As of 09:54AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-173,718,000
-74,512,000
56,413,000
56,219,000
Depreciation & amortisation
37,434,000
41,263,000
38,348,000
22,673,000
Change in working capital
-54,919,000
34,878,000
-33,733,000
66,327,000
Inventory
-10,434,000
4,560,000
5,356,000
-10,039,000
Other working capital
-289,514,000
-805,000
17,745,000
124,795,000
Other non-cash items
-61,364,000
-41,621,000
-9,984,000
8,325,000
Net cash provided by operating activities
-275,326,000
11,937,000
31,239,000
135,601,000
Cash flows from investing activities
Investments in property, plant and equipment
-14,188,000
-12,742,000
-13,494,000
-10,806,000
Purchases of investments
-4,485,000
-6,247,000
-25,905,000
-9,366,000
Sales/maturities of investments
32,064,000
10,068,000
19,472,000
8,141,000
Other investing activities
-
2,047,000
-1,124,000
225,000
Net cash used for investing activities
69,074,000
52,419,000
-18,278,000
8,875,000
Net change in cash
-247,937,000
-82,461,000
-8,465,000
87,261,000
Cash at beginning of period
265,773,000
202,984,000
193,698,000
101,708,000
Cash at end of period
17,836,000
143,478,000
202,984,000
193,698,000
Free cash flow
Operating cash flow
-275,326,000
11,937,000
31,239,000
135,601,000
Capital expenditure
-14,188,000
-12,742,000
-13,494,000
-10,806,000
Free cash flow
-289,514,000
-805,000
17,745,000
124,795,000